Trials / Completed
CompletedNCT00996190
Best Regimen for Phenylephrine Administration During Cesarean Section
Study to Determine the Best Regimen for Administration of Phenylephrine During Spinal Anesthesia for Cesarean Delivery, as Determined by Maternal Blood Pressure and Cardiac Output
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Samuel Lunenfeld Research Institute, Mount Sinai Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
During Cesarean delivery, phenylephrine is used to maintain the patient's blood pressure. Low blood pressure is the most common side effect of the spinal medication used to anesthetize the patient prior to the start of surgery. This low blood pressure can also trigger unpleasant side effects such as nausea, vomiting and low Apgar scores for the baby. Currently there are 2 methods of phenylephrine administration during Cesarean section. One method is by intermittent bolus and the other is by continuous infusion. It is ideal to have a regimen for phenylephrine administration that maintains blood pressure without compromising cardiac output. In this study, cardiac output and blood pressure will be measured by transthoracic bioimpedance, which is a new technique of noninvasive continuous cardiac output monitoring. The hypothesis of this study is that the continuous infusion of phenylephrine will be equally effective in maintaining blood pressure as compared to the intermittent injection, and will induce less hemodynamic changes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Phenylephrine | phenylephrine 120 micrograms/mL, administered either by continuous infusion or by intermittent bolus dose |
Timeline
- Start date
- 2009-11-01
- Primary completion
- 2010-08-01
- Completion
- 2010-08-01
- First posted
- 2009-10-16
- Last updated
- 2011-02-23
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00996190. Inclusion in this directory is not an endorsement.